Isotechnika Announces Preliminary 48 Week Clinical Data From the Juraforum.de, Germany - Mar 20, 2006 (TSX:ISA) announced today preliminary 48 week clinical data obtained from its Phase III psoriasis and extension trials for its lead immunosuppressive drug
Read The Full Article:
http://www.drilltools.org/275
Add to del.icio.us
Digg this
Post to Furl
Add to reddit
Add to myYahoo!
Powered by blogdig.net